Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Gains from Sales and Divestitures (2021 - 2025)

iBio (IBIO) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $35369.0 as the latest value for Q2 2025.

  • Quarterly Gains from Sales and Divestitures fell 15.9% to $35369.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $35369.0 through Jun 2025, down 15.9% year-over-year, with the annual reading at $35369.0 for FY2025, 15.9% down from the prior year.
  • Gains from Sales and Divestitures for Q2 2025 was $35369.0 at iBio, up from $11575.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $42054.0 in Q2 2024, with the low at $11.0 in Q3 2024.
  • Average Gains from Sales and Divestitures over 5 years is $11366.8, with a median of $4709.0 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures surged 1008.44% in 2022, then tumbled 99.78% in 2024.
  • Over 5 years, Gains from Sales and Divestitures stood at $4120.0 in 2021, then soared by 114.9% to $8854.0 in 2022, then crashed by 44.08% to $4951.0 in 2023, then crashed by 99.78% to $11.0 in 2024, then soared by 321436.36% to $35369.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $35369.0, $11575.0, and $11.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.